1. Home
  2. LUCD vs SPOK Comparison

LUCD vs SPOK Comparison

Compare LUCD & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

HOLD

Current Price

$0.49

Market Cap

192.9M

Sector

Health Care

ML Signal

HOLD

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

SELL

Current Price

$10.57

Market Cap

218.8M

ML Signal

SELL

Company Overview

Basic Information
Metric
LUCD
SPOK
Founded
2018
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
192.9M
218.8M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
LUCD
SPOK
Price
$0.49
$10.57
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $4.00
N/A
AVG Volume (30 Days)
★ 1.7M
113.4K
Earning Date
11-11-2026
11-02-2026
Dividend Yield
N/A
★ 11.78%
EPS Growth
★ 16.67
2.74
EPS
N/A
★ 0.29
Revenue
$4,346,000.00
★ $139,708,000.00
Revenue This Year
$33.93
N/A
Revenue Next Year
$165.18
N/A
P/E Ratio
★ N/A
$36.59
Revenue Growth
★ 79.00
1.49
52 Week Low
$0.47
$9.95
52 Week High
$1.63
$16.45

Technical Indicators

Market Signals
Indicator
LUCD
SPOK
Relative Strength Index (RSI) 22.17 45.17
Support Level N/A $10.28
Resistance Level $1.09 $10.87
Average True Range (ATR) 0.07 0.20
MACD -0.01 -0.01
Stochastic Oscillator 0.69 31.51

Price Performance

Historical Comparison
LUCD
SPOK

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: